SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for dangerous fat levels in blood
Disease control OngoingThis study tests the long-term safety of a drug called olezarsen in people with severely high triglycerides, a condition that raises the risk of pancreatitis and heart disease. About 885 participants who completed earlier studies will receive olezarsen injections for up to three …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug plozasiran aims to tame dangerous fat levels in blood
Disease control OngoingThis Phase 3 trial tests plozasiran, an injectable drug, in 446 adults with severe hypertriglyceridemia (very high blood fats). Participants receive four doses over 12 months, and researchers measure how much triglyceride levels drop compared to placebo. The goal is to see if plo…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug plozasiran aims to tame dangerous fat levels in blood
Disease control OngoingThis Phase 3 study tests a drug called plozasiran in 311 adults with severe hypertriglyceridemia, a condition where blood fat levels are very high and raise the risk of pancreatitis. Participants receive four injections over a year, either the drug or a placebo. The main goal is …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC